Ubs Asset Management Americas Inc Gilead Sciences, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 13,755,481 shares of GILD stock, worth $1.5 Billion. This represents 0.41% of its overall portfolio holdings.
Number of Shares
13,755,481
Previous 12,234,672
12.43%
Holding current value
$1.5 Billion
Previous $1.13 Billion
36.38%
% of portfolio
0.41%
Previous 0.27%
Shares
30 transactions
Others Institutions Holding GILD
# of Institutions
2,286Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.8 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.51 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.97 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.85 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $137B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...